Most Recent Links

Follow us on Facebook and Twitter, or subscribe to our mailing list, to receive news updates. Learn more.

Links 21 - 40 of 24763

Ian Sample Science editor Claims that US diplomats suffered mysterious brain injuries after being targeted with a secret weapon in Cuba have been challenged by neurologists and other brain specialists. A medical report commissioned by the US government, published in March, found that staff at the US embassy in Havana suffered concussion-like brain damage after hearing strange noises in homes and hotels, but doctors from the US, the UK and Germany have contested the conclusions. In four separate letters to the Journal of the American Medical Association, which published the original medical study, groups of doctors specialising in neurology, neuropsychiatry and neuropsychology described what they believed were major flaws in the study. Among the criticisms, published on Tuesday, are that the University of Pennsylvania team which assessed the diplomats misinterpreted test results, overlooked common disorders that might have made the workers feel sick, or dismissed psychological explanations for their symptoms. Doctors at the University of Pennsylvania defended their report in a formal response in the journal, but the specialists told the Guardian they stood by their criticisms. The US withdrew more than half of its Havana diplomats last year and expelled 15 Cubans after 24 embassy staff and family reported a bizarre list of symptoms, ranging from headaches, dizziness and difficulties in sleeping, to problems with concentration, balance, vision and hearing. Many said their symptoms developed after they heard strange noises, described as cicada-like chirps, grinding, or the buffeting caused by an open window in the car. © 2018 Guardian News and Media Limited

Keyword: Brain Injury/Concussion; Hearing
Link ID: 25334 - Posted: 08.15.2018

Yao-Hua Law What can males wear to look sexier? For zebra finches, the trick seemed simple: add a dash of red to their legs. Research conducted in the 1980s found that slipping red bands onto the legs of male birds turned them into sex magnets. Those studies became iconic in sexual selection research because they provided something rare in the discipline: strong, consistent effects. But data accumulated in recent years question these influential findings. Zebra finches (Taeniopygia guttata) are native Australian birds with a bright red-orange beak. They form monogamous breeding pairs in which the male and female cooperate to raise young. Easy to rear in captivity, zebra finches are model organisms for research in cognition and sexual selection. In the 1980s, ornithologist Nancy Burley, then at the University of Illinois, found that placing plastic leg bands of different colors—used by scientists to identify individual birds—on the legs of zebra finches affected the birds’ chances of mating. Burley reported, first in Science and then in other leading journals, that females preferred red-banded males and disliked green-banded males. Females also spent more time caring for nestlings sired by red-banded males. Burley’s results inspired subsequent research in female choice and maternal effects. But results contradictory to Burley’s began to emerge in the late 1990s. And this March, Wolfgang Forstmeier of the Max Planck Institute for Ornithology and colleagues published the strongest disagreement yet. Forstmeier’s lab ran eight experiments and analyzed unpublished data from four other labs and found no effects of leg-band colors on the reproductive success of male or female zebra finches. The new study also included a meta-analysis of 39 published studies, including 22 that supported leg-band color effects. The meta-analysis found that effect sizes shrank as sample sizes increased—a sign of selective reporting. © 1986 - 2018 The Scientist

Keyword: Sexual Behavior; Evolution
Link ID: 25333 - Posted: 08.15.2018

by Lindsey Bever New research has shown that a common childhood vaccination given to pregnant women does not put their children at any increased risk of autism. A Kaiser Permanente study published Monday in the journal Pediatrics found no association between the prenatal Tdap (for tetanus, diphtheria and pertussis, also known as whooping cough) vaccine and autism spectrum disorder when looking at tens of thousands of children in the hospital system. It is the latest in a long line of studies showing that there is no link between vaccines and autism. Despite the abundant scientific evidence, a persistent conspiracy theory has misled some parents into fearing vaccines. “If any woman had any hesitancy, she can be reassured,” Tracy Becerra-Culqui, lead author and postdoctoral research fellow with Kaiser Permanente Southern California's department of research and evaluation, told The Washington Post. When not vaccinated, she said, “the risk of getting whooping cough is greater than any perceived risk of harm to the baby, so it should be a no-brainer to accept the vaccine.” The Centers for Disease Control and Prevention, the American College of Obstetricians and Gynecologists, and the American College of Nurse-Midwives encourage expectant mothers to get the Tdap vaccine in the third trimester of pregnancy to protect babies from bacterial infections that can be fatal for infants. © 1996-2018 The Washington Post

Keyword: Autism; Neuroimmunology
Link ID: 25332 - Posted: 08.15.2018

Sarah Boseley Health editor A new drug to relieve pain during labour works better than pethidine, which has been in widespread use since the 1950s even though it has long been known it does not help all women, say researchers. Pethidine is given as an injection, but a new study funded by the National Institute for Health Research shows that remifentanil, which women control by pressing a button when they feel pain, appears to be more effective. Women using remifentanil were half as likely to end up asking for an epidural, which blocks all pain and sensation and often leads to a forceps delivery. Pethidine was the first opioid drug that was allowed to be given by a midwife alone and was very widely adopted, said Dr Matthew Wilson, a senior lecturer at the University of Sheffield and the lead author of the study published in the Lancet medical journal. More than a quarter of a million women in labour are given pethidine each year in the UK, even though up to 40% do not find it helpful, he said. “Some women do not report any useful pain relief at all and it has significant side effects,” he said. That includes sedation and potentially affecting the baby. “There has been a longstanding need for something else,” he said. Epidurals are by far the most effective form of pain relief, but women who have them are more likely to end up with their baby having a forceps or vacuum delivery. That can sometimes cause damage to the mother and have long-term consequences, including sexual problems. © 2018 Guardian News and Media Limited

Keyword: Pain & Touch
Link ID: 25331 - Posted: 08.15.2018

by Amy Ellis Nutt Traumatic brain injury is the leading cause of death and disability in young adults in the developed world. Suicide is the second leading cause of death for young people ages 15 to 24. Though the reasons for any particular suicide are often inscrutable, research published Tuesday in the Journal of the American Medical Association suggests that at least a fraction of the blame could be placed on traumatic brain injuries. Researchers found that of the nearly 7.5 million people who make up the population of Denmark, more than 34,500 deaths between 1980 and 2014 were by suicide. Approximately 10 percent of those who took their own lives had also suffered a medically documented traumatic brain injury. The statistical analysis was conducted using the Danish Cause of Death registry. “Individuals with mild TBI, with concussion, had an elevated suicide risk by 81 percent,” said Trine Madsen of the Danish Research Institute of Suicide Prevention, one of the authors of the study. “But individuals with severe TBI had a higher suicide risk that was more than double [the risk of someone with no TBI].” Three factors most strongly predicted the risk of suicide: the severity of the traumatic brain injury, a first incidence occurring in young adulthood and discharge from a hospital for a TBI in the previous six months. Seena Fazel, a forensic psychiatrist at the University of Oxford, has studied TBIs and health risks, including mental health issues, in large Scandinavian populations as well. “What is important in this study,” Fazel said, “is that we can say that these risks are also found when TBIs are sustained in childhood.” © 1996-2018 The Washington Post

Keyword: Brain Injury/Concussion; Depression
Link ID: 25330 - Posted: 08.15.2018

Tina Hesman Saey Some snippets of RNA can be a real pain. A microRNA called miR-30c-5p contributes to nerve pain in rats and people, a new study finds. A different microRNA, miR-711, interacts with a well-known itch-inducing protein to cause itching, a second study concludes. Together, the research highlights the important role that the small pieces of genetic material can play in nerve cell function, and may help researchers understand the causes of chronic nerve pain and itch. MicroRNAs help regulate gene activity and protein production. The small molecules play a big role in controlling cancer (SN: 8/28/10, p. 18) and other aspects of health and disease (SN: 2/20/16, p. 18). Usually, microRNAs work by pairing up with bigger pieces of RNA called messenger RNAs, or mRNA. Messenger RNAs contain copies of genetic instructions that are read by cellular machinery to build proteins. When microRNAs glom onto the messengers, the mRNA can be degraded or the microRNAs can prevent the protein-building machinery from reading the instructions. Either way, the result is typically to dial down production of certain proteins. In the case of nerve pain, miR-30c-5p limits production of an important protein called TGF-beta that’s involved in controlling pain, María Hurlé, a pharmacologist at the University of Cantabria in Santander, Spain, and colleagues report August 8 in Science Translational Medicine. The researchers discovered the link in experiments with mice, rats and people. |© Society for Science & the Public 2000 - 2018.

Keyword: Pain & Touch
Link ID: 25329 - Posted: 08.14.2018

Mike Robinson To call gambling a “game of chance” evokes fun, random luck and a sense of collective engagement. These playful connotations may be part of why almost 80 percent of American adults gamble at some point in their lifetime. When I ask my psychology students why they think people gamble, the most frequent suggestions are for pleasure, money or the thrill. While these might be reasons why people gamble initially, psychologists don’t definitely know why, for some, gambling stops being an enjoyable diversion and becomes compulsive. What keeps people playing even when it stops being fun? Why stick with games people know are designed for them to lose? Are some people just more unlucky than the rest of us, or simply worse at calculating the odds? As an addiction researcher for the past 15 years, I look to the brain to understand the hooks that make gambling so compelling. I’ve found that many are intentionally hidden in how the games are designed. And these hooks work on casual casino-goers just as well as they do on problem gamblers. Uncertainty as its own reward in the brain One of the hallmarks of gambling is its uncertainty – whether it’s the size of a jackpot or the probability of winning at all. And reward uncertainty plays a crucial role in gambling’s attraction. Dopamine, the neurotransmitter the brain releases during enjoyable activities such as eating, sex and drugs, is also released during situations where the reward is uncertain. In fact dopamine release increases particularly during the moments leading up to a potential reward. © 2010–2018, The Conversation US, Inc.

Keyword: Drug Abuse; Attention
Link ID: 25328 - Posted: 08.14.2018

By Matt Neal Sir John Eccles is an icon of Australian science, but an attempt in later life to mix religion and science made him an outsider in the scientific community as it won him fans in the Catholic Church. In 1963, along with British biophysicists Sir Alan Hodgkin and Sir Andrew Huxley, he won the Nobel Prize for Physiology or Medicine for their groundbreaking work on synapses and the electrical properties of neurons. How Sir John revolutionised neuroscience: He shared the 1963 Nobel Prize for Physiology Or Medicine with Alan Lloyd Hodgkin and Andrew Fielding Huxley "for their discoveries concerning the ionic mechanisms involved in excitation and inhibition in the peripheral and central portions of the nerve cell membrane" Eccles' work showed that the transmission of information and impulses between neurons in the brain was both electrical and chemical in nature His experiments paved the way for treatments of nervous diseases as well as further research into the brain, heart and kidneys That same year, Eccles was named Australian of the Year. But, as University of Sydney Honorary Associate Professor John Carmody once wrote: "the nation appears to have forgotten [Eccles despite the fact] modern neuroscience is forever in his debt". Part of the reason for the decline in his regard could stem from his latter-career work, in which he controversially attempted to marry his scientific prowess with his religious beliefs, and went in search of the soul. © 2018 ABC

Keyword: Consciousness
Link ID: 25327 - Posted: 08.14.2018

Laura Sanders To understand the human brain, take note of the rare, the strange and the downright spooky. That’s the premise of two new books, Unthinkable by science writer Helen Thomson and The Disordered Mind by neuroscientist Eric R. Kandel. Both books describe people with minds that don’t work the same way as everyone else’s. These are people who are convinced that they are dead, for instance; people whose mental illnesses lead to incredible art; people whose memories have been stolen by dementia; people who don’t forget anything. By scrutinizing these cases, the stories offer extreme examples of how the brain creates our realities. In the tradition of the late neurologist Oliver Sacks (SN: 10/14/17, p. 28), Thomson explores the experiences of nine people with unusual minds. She travels around the world to interview her subjects with compassion and curiosity. In England, she meets a man who, following a bathtub electrocution, became convinced that he was dead. (Every so often, he still feels “a little bit dead,” he tells Thomson.) In Los Angeles, she spends time with a 64-year-old man who can remember almost every day of his life in extreme detail. And in a frightening encounter in a hospital in the United Arab Emirates, she interviews a man with schizophrenia who transmogrifies into a growling tiger. By visiting them in their element, Thomson presents these people not as parlor tricks, but as fully rendered human beings. Kandel chooses the brain disorders themselves as his subjects. He explains the current neuroscientific understanding of autism, depression and schizophrenia, for example, by weaving together the history of the research and human examples. His chapter on dementia and memory is particularly compelling, given his own Nobel Prize–winning role in revealing how brains form memories (SN: 10/14/00, p. 247). |© Society for Science & the Public 2000 - 2018

Keyword: Miscellaneous
Link ID: 25326 - Posted: 08.14.2018

Philip Ball Carl Zimmer is a rarity among professional science writers in being influential among the scientists on whose work he writes and comments – to the extent that he has been appointed as professor adjunct in the department of molecular biophysics and biochemistry at Yale University. Zimmer has just published his 13th book, She Has Her Mother’s Laugh, a survey of “the power, perversions and potential of heredity”. What is the book’s main message about our attitudes to heredity? Heredity is central to our existence and how we define ourselves. But it’s not what we think it is. It’s not just genes, for example. We inherit culture too, and there may even be other channels of heredity. And the way genes enable heredity doesn’t fit our common notions. We tend to imagine that we inherit particular genes from our parents, grandparents and so on, and that these shape us in ways that are easy to understand and trace. But that’s not how heredity works. Each trait is typically influenced by hundreds or thousands of different genes, and the environment in which those genes are acting makes all the difference to how we turn out. You talk in the book about how some of these questions were brought home to you when your first daughter was born in 2001. What’s your personal journey into the story of heredity? In 2000 my wife was pregnant with our first child, and our doctor asked us to go to a genetics counsellor. I thought this was pointless. But the counsellor started asking me questions and I suddenly realised I had a really terrible grasp of my family history. I felt very ashamed and irresponsible, because here was this child who would be inheriting a lot of my genes. This was the first time heredity went from being something I learned about in class to one of the most important things in my existence. © 2018 Guardian News and Media Limited

Keyword: Genes & Behavior; Development of the Brain
Link ID: 25325 - Posted: 08.13.2018

By Jane E. Brody Attention all you happy high school graduates about to go off to college, as well as the many others returning for another year of higher education. Grandsons Stefan and Tomas, that includes you. Whatever you may think can get in the way of a successful college experience, chances are you won’t think of one of the most important factors: how long and how well you sleep. And not just on weekends, but every day, Monday through Sunday. Studies have shown that sleep quantity and sleep quality equal or outrank such popular campus concerns as alcohol and drug use in predicting student grades and a student’s chances of graduating. Although in one survey 60 percent of students said they wanted information from their colleges on how to manage sleep problems, few institutions of higher learning do anything to counter the devastating effects of sleep deprivation on academic success and physical and emotional well-being. Some, in fact, do just the opposite, for example, providing 24-hour library hours that encourage students to pull all-nighters. (I did that only once, to study for an exam in freshman year, and fell asleep in the middle of the test. Lesson well learned!) An all-nighter may help if all you have to do is memorize a list, but if you have to do something complex with the information, you’ll do worse by staying up all night, J. Roxanne Prichard, an expert on college sleep issues, told me. After being awake 16 hours in a row, brain function starts to decline, and after 20 hours awake, you perform as if legally drunk, she said. Many college-bound kids start out with dreadful sleep habits that are likely to get worse once the rigorous demands of college courses and competing social and athletic activities kick in. © 2018 The New York Times Company

Keyword: Sleep; Learning & Memory
Link ID: 25324 - Posted: 08.13.2018

By Jessica Wright, Boosting levels of the chemical messenger serotonin makes mice that model autism more social, according to a study published in Nature. The study suggests the approach may do the same in people with autism. It also offers an explanation for why antidepressants do not ease autism traits: They may increase serotonin levels too slowly to be effective. The researchers used a technique that rapidly increases serotonin levels in the nucleus accumbens, a brain region that mediates social reward. “Somehow, the release of serotonin in the nucleus accumbens really plays an important role in enhancing sociability,” says lead researcher Robert Malenka, professor of psychiatry and behavioral sciences at Stanford University in California. “The simple hypothesis is it makes the social interaction more reinforcing.” Decades of research have suggested a connection between serotonin and autism. About 10 years ago, this led researchers to test antidepressants, which increase serotonin levels by blocking its reabsorption into neurons, as a treatment for autism. However, in several trials, antidepressants such as fluoxetine (Prozac) proved ineffective at easing the condition’s features. The new study suggests that a drug that rapidly activates serotonin receptors would be a more effective way of treating the condition. © 2018 Scientific American

Keyword: Autism
Link ID: 25323 - Posted: 08.13.2018

Michaeleen Doucleff My back hurts when I sit down. It's been going on for 10 years. It really doesn't matter where I am — at work, at a restaurant, even on our couch at home. My lower back screams, "Stop sitting!" To try to reduce the pain, I bought a kneeling chair at work. Then I got a standing desk. Then I went back to a regular chair because standing became painful. I've seen physical therapists, orthopedic surgeons and pain specialists. I've mastered Pilates, increased flexibility and strengthened muscles. At one point, my abs were so strong my husband nicknamed them "the plate." All these treatments helped a bit, at first. But the pain never really went away. So a few years ago, I decided to accept reality: Sitting down is — and will always be — painful for me. Then back in November, I walked into the studio of Jenn Sherer in Palo Alto, Calif. She is part of a growing movement on the West Coast to teach people to move and sit and stand as they did in the past — and as they still do in other parts of the world. I was interviewing Sherer for a story about bending. But she could tell I was in pain. So I told her my story. Her response left me speechless: "Sitting is a place where you can find heaven in your joints and in your back," she says. "It's not sitting that's causing the pain, it's how you're sitting. "Do you want me to show you how?" © 2018 npr

Keyword: Pain & Touch
Link ID: 25322 - Posted: 08.13.2018

Ann Robinson Imagine a neurological condition that affects one in 20 under-18s. It starts early, causes significant distress and pain to the child, damages families and limits the chances of leading a fulfilled life as an adult. One in 20 children are affected but only half of these will get a diagnosis and a fifth will receive treatment. If those stats related to a familiar and well-understood illness, such as asthma, there would be little debate about the need to improve intervention rates. But this is attention deficit hyperactivity disorder (ADHD), and the outcry is muted. If anything, we hear warnings that too many children are being labelled this way, and too many given prescriptions. In the United States, ADHD is diagnosed at more than twice the incidence in Britain. The true prevalence is likely to be the same on both sides of the Atlantic. So what’s the story? Is the US too gung-ho, or is the UK dragging its heels? Are American doctors too quick to medicate children, or British doctors too slow? Emily Simonoff, co-author of a new meta-analysis in the journal the Lancet Psychiatry, says the problem in the UK is “predominantly about undermedication and underdiagnosis”. Her study examined a range of drug treatments compared to placebo, and it shows that methylphenidate (better known by under the brand name Ritalin) works best for children and amphetamines for adults. © 2018 Guardian News and Media Limited

Keyword: ADHD; Drug Abuse
Link ID: 25321 - Posted: 08.13.2018

by Antonia Noori Farzan It’s been well-documented that a decreased sex drive can be one of the side effects of antidepressants like Prozac. But the amount of these drugs that end up in sewage plants may also have an impact on the mating habits of wild birds, a new study from the University of York shows. Researchers found that female starlings that had been exposed to small doses of fluoxetine, the generic name for Prozac, became less attractive to male starlings, which sung to them less often and treated them more aggressively. Kathryn Arnold, one of the study’s authors and a senior lecturer in ecology at the University of York, described it as “the first evidence that low concentrations of an antidepressant can disrupt the courtship of songbirds.” That’s problematic because birds that are slow to find a mate may not get the chance to breed, she wrote. “We’re definitely not saying that it’s bad to take antidepressants, but certainly there is a greater need for new technologies to clean out sewage,” Arnold told The Washington Post. Birds like to graze at sewage treatment plants, which are teeming with worms, flies and maggots, she explained. But because antidepressants often make their way through the human body and into sewage plants without fully breaking down, those insects are frequently laced with prescription drugs. © 1996-2018 The Washington Post

Keyword: Depression; Sexual Behavior
Link ID: 25320 - Posted: 08.13.2018

There is a new study on the effect treating teens for depression has on their parents. It suggests just treating teens has benefits for parents. LULU GARCIA-NAVARRO, HOST: There are estimates that 13 percent of adolescents in the United States experience at least one episode of major depression. That depression can be treated in teens. And new research suggests that it helps not just them but also their parents. NPR's Rhitu Chatterjee reports. RHITU CHATTERJEE, BYLINE: We tend to think of depression as affecting individuals, but Myrna Weissman says... MYRNA WEISSMAN: Depression is a family affair. CHATTERJEE: Weissman is a professor of psychiatry at the College of Physicians and Surgeons at Columbia University. And she's studied depression in families for years. WEISSMAN: We know that there's high rates of depression in the offspring of depressed mothers. CHATTERJEE: Weissman's previous work has shown that when mothers are treated for depression, their children feel better, as well. That led another researcher, Kelsey Howard, to wonder, could the opposite be true? KELSEY HOWARD: So if kids get better, do parents then feel better? And we found that to be true, as well. CHATTERJEE: Howard is a graduate student at the department of Psychiatry and Behavioral Sciences at Northwestern University. To answer her question, she and her graduate adviser analyzed data from a previous study that followed more than 300 teenagers getting treatment for depression either through counseling or pills or both. Before and during the course of the study, the researchers had also surveyed one parent of each teenager for symptoms of depression. When Howard looked at that data, she found that... © 2018 npr

Keyword: Depression; Development of the Brain
Link ID: 25319 - Posted: 08.13.2018

Pamela Duncan and Nicola Davis More than four million people in England are long-term users of antidepressants, new figures obtained by the Guardian show. Data released under the Freedom of Information Act shows that more than 7.3 million people were prescribed antidepressants in 2017-18, 4.4 million of whom also received a prescription for such drugs in both of the two previous years. 1.6 million people prescribed antidepressants in the past year were “new” users, meaning they were not being prescribed such drugs in either 2015-16 or 2016-17. The figures also show the number of such “new” users of antidepressants is falling. Month-by-month figures show an overall decline from just over 179,000 “new” starters in April 2016 to just over 132,000 in March 2018. Experts say it is not clear what is behind the trend and that there could be a number of factors at play. Scott Weich, a professor of mental health at the University of Sheffield, said the tendency to prescribe antidepressants seems to have gone in phases over recent decades. “Professionals may be becoming slightly less certain about the benefits of antidepressants [for mild depression], and patients themselves may be declining medication,” he said. Weich noted other reasons might be that individuals are finding it increasingly difficult to access GP services to discuss mental health issues, or that the issues are not discussed due to time constraints or other pressures. On the other hand, he said, it could in part reflect the rise in so-called “talking therapies” like CBT. © 2018 Guardian News and Media Limited

Keyword: Depression
Link ID: 25318 - Posted: 08.11.2018

Public awareness of the debilitating impact of postpartum depression on new moms has grown over the years, but many people don't realize it can affect men too, mental health experts say. In a series of presentations at the American Psychological Association annual convention this week, a group of psychologists said about 10 per cent of new fathers experience symptoms of depression and anxiety in the weeks before, during or after their babies are born. "One of the main myths is men don't experience hormonal changes, therefore they can't get postpartum depression or anxiety," said Daniel Singley, one of the presenters and a psychologist based in San Diego, Calif. "In fact, plenty of research shows that men do get hormonal changes around the birth of children, and that hormonal changes is just one of a number of bio-psychosocial factors that cause postpartum mood issues," he said. The Canadian Mental Health Association acknowledges that men and women and even parents who adopt can suffer from the condition, noting on its website that "a mother or father with postpartum depression may not enjoy the baby and have frequent thoughts that they're a bad parent." Dealing with the issue of postpartum depression in men is important for the well-being of their children, Singley said, because fathers experiencing it are "much less likely" to be involved with their newborns — which, in turn, can negatively affect the babies' development. ©2018 CBC/Radio-Canada

Keyword: Depression
Link ID: 25317 - Posted: 08.11.2018

Laurel Hamers A Nobel Prize–winning discovery — that small double-stranded RNA molecules can silence genes by interrupting the translation of DNA’s instructions into proteins — is finally delivering on its medical promise. The first drug that takes advantage of this natural biological process, called RNA interference, was approved August 10 by the U.S. Food and Drug Administration. It targets a rare hereditary disease that causes misshapen proteins to build up in patients’ nerves, tissues and organs, causing loss of sensation, organ failure and even death. Heredity transthyretin amyloidosis, or ATTR, affects about 50,000 people worldwide. This drug will help the subset of those patients who have neurological impairments. Called patisiran, the drug uses specially designed pieces of RNA to silence a mutated gene that, when active in the liver, is responsible for patients’ symptoms. In a recent 18-month clinical trial, patients who received patisiran injections every three weeks showed a slight decrease in neurological symptoms, whereas patients on the placebo worsened overall. It’s not a cure — people still have the genetic mutation — but the treatment prevents the disease from progressing. This approval is “just the beginning,” says Craig Mello of the University of Massachusetts Medical School in Worcester, who co-discovered the process of RNA interference in roundworms (SN: 10/7/06, p. 229). Many more drugs using the same approach, for diseases ranging from hemophilia to HIV, are winding through clinical trials. |© Society for Science & the Public 2000 - 2018

Keyword: Genes & Behavior
Link ID: 25316 - Posted: 08.11.2018

Scientists say they have found how blue light from smartphones, laptops and other digital devices damages vision and can speed up blindness. Research by the University of Toledo in the US has revealed that prolonged exposure to blue light triggers poisonous molecules to be generated in the eye’s light-sensitive cells that can cause macular degeneration – an incurable condition that affects the middle part of vision. Blue light, which has a shorter wavelength and more energy compared with other colours, can gradually cause damage to the eyes. Dr Ajith Karunarathne, an assistant professor in the university’s department of chemistry and biochemistry, said: “We are being exposed to blue light continuously and the eye’s cornea and lens cannot block or reflect it. “It’s no secret that blue light harms our vision by damaging the eye’s retina. Our experiments explain how this happens, and we hope this leads to therapies that slow macular degeneration, such as a new kind of eye drop.” Macular degeneration, which affects around 2.4% of the adult population in the UK, is a common condition among those in their 50s and 60s that results in significant vision loss. It is caused by the death of photoreceptor, ie light-sensitive cells, in the retina. Age-related macular degeneration is the leading cause of blindness in the US and while it does not cause total blindness, it can make everyday activities such as reading and recognising faces difficult. © 2018 Guardian News and Media Limite

Keyword: Vision
Link ID: 25315 - Posted: 08.10.2018